Mick Farrell

Chairman & CEO, ResMed

CEOMedical Devices

Michael "Mick" Farrell is the Chairman and Chief Executive Officer of ResMed, the San Diego-headquartered medical device and digital health company specialising in sleep apnoea and respiratory care. He has served as CEO since March 2013 and became Chairman of the board in January 2023, having joined the company more than 25 years ago.

Fast facts

Role	Chairman & CEO
Company	ResMed ASX:RMD
Sector	Medical Devices / Healthcare
In role since	2013
Education	Bachelor of Engineering with first-class honours from the University of New South Wales; Master of Science in chemical engineering from MIT; MBA from the MIT Sloan School of Management.
Other roles	Chair, AdvaMed (medical device industry association, from 2026).

Background

CEO since 2013 (also Chairman); led ResMed's growth in sleep apnoea and respiratory devices and digital health/SaaS. San Diego-headquartered; ASX-listed via CDIs (RMD). Named Chair of AdvaMed from January 2026.

Career timeline

2007Became Senior Vice President of ResMed's global sleep apnea business unit
2011Appointed President of the Americas region at ResMed
2013Appointed CEO of ResMed and joined the board in March
2023Became Chairman of the ResMed board in January

Notable

Has served as a director of Zimmer Biomet since December 2014
Appointed Chair of the Advanced Medical Technology Association (AdvaMed) for a two-year term starting January 2026
Before ResMed worked at Arthur D. Little, Sanofi Genzyme, Dow Chemical and BHP

Frequently asked questions

When did Mick Farrell become CEO of ResMed?

He was appointed CEO of ResMed in March 2013 and became Chairman in January 2023.

Where is ResMed headquartered?

ResMed is headquartered in San Diego, California, and is also listed on the ASX via CDIs.

Public profiles

https://www.resmed.com/en-us/about-us/executive-team/

Sources

Last verified 2026-07-13. Professionally-public, sourced information only.